Legend Biotech Corp Depreciation Property Plant And Equipment
Legend Biotech Corp (LEGN) reported Depreciation Property Plant And Equipment of $9.40 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DepreciationPropertyPlantAndEquipment · last filed 2026-03-10
- Legend Biotech Corp depreciation property plant and equipment for the quarter ending 2024-12-31 was $2.74M, a 0.62% increase year-over-year.
- Legend Biotech Corp depreciation property plant and equipment for the quarter ending 2024-09-30 was $2.38M, a 10.99% decline year-over-year.
- Legend Biotech Corp depreciation property plant and equipment for the quarter ending 2024-06-30 was $2.78M.
- Legend Biotech Corp depreciation property plant and equipment for the quarter ending 2024-03-31 was $2.80M.
| Period end | Depreciation Property Plant And Equipment 3 month | Depreciation Property Plant And Equipment 6 month | Depreciation Property Plant And Equipment 9 month | Depreciation Property Plant And Equipment 12 month | Depreciation Property Plant And Equipment 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $9.40M 20-F · filed 2026-03-10 | ||||
| 2024-12-31 | $2.74M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $5.12M derived: sum of 2 quarters · filed 2026-03-10 | $7.90M derived: sum of 3 quarters · filed 2026-03-10 | $10.70M 20-F · filed 2026-03-10 | |
| 2024-09-30 | $2.38M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $5.16M derived: sum of 2 quarters · filed 2024-11-12 | $7.96M 6-K · filed 2024-11-12 | $10.68M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2024-06-30 | $2.78M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | $5.58M 6-K · filed 2024-08-09 | $8.30M derived: sum of 3 quarters · filed 2025-03-11 | $10.98M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2024-03-31 | $2.80M 6-K · filed 2024-05-13 | $5.52M derived: sum of 2 quarters · filed 2025-03-11 | $8.20M derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2023-12-31 | $2.73M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $5.40M derived: sum of 2 quarters · filed 2025-03-11 | $10.70M 20-F · filed 2025-03-11 | ||
| 2023-09-30 | $2.67M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $7.98M 6-K · filed 2023-11-20 | |||
| 2023-06-30 | $5.30M 6-K · filed 2023-08-15 | ||||
| 2022-12-31 | $10.17M 20-F · filed 2024-03-19 | ||||
| 2021-12-31 | $8.14M 20-F · filed 2023-03-30 | $11.05M 20-F · filed 2022-03-31 | |||
| 2020-12-31 | $6.23M 20-F/A · filed 2023-02-17 | $8.25M 20-F · filed 2021-04-02 | |||
| 2019-12-31 | $4.00M 20-F · filed 2021-04-02 |